
Nexolid200 mg
Renata Limited
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Tedizolid Phosphate is an FDA-approved, established treatment for acute bacterial skin and skin structure infections (ABSSSI) in adults…
Tedizolid Phosphate is an FDA-approved, established treatment for acute bacterial skin and skin structure infections (ABSSSI) in adults and adolescents (12 years of age and older), caused by susceptible Gram-positive organisms. Documented susceptible organisms include Staphylococcus aureus (including methicillin-resistant strains, MRSA, and methicillin-susceptible strains, MSSA), Streptococcus pyogenes, Streptococcus agalactiae, the Streptococcus anginosus group (including S. anginosus, S. intermedius, and S. constellatus), and Enterococcus faecalis. Tedizolid Phosphate is useful when infection is known or suspected to involve MRSA, or when oral step-down therapy from an intravenous antibiotic is desired.
Tedizolid Phosphate is not approved for, and should not be used to treat, other types of infection such as community-acquired pneumonia, bloodstream infections, or infections caused by Gram-negative bacteria; clinical trials of Tedizolid Phosphate for indications outside ABSSSI have not established a favorable benefit-risk profile, and off-label use of Tedizolid Phosphate for such infections is not recommended outside specialist guidance.
The recommended dose of Tedizolid Phosphate for its approved indication, acute bacterial skin and skin structure infections (ABSSSI), is fixed and does not require adjustment for body weight, renal function, or mild-to-moderate hepatic impairment. The oral and intravenous forms of Tedizolid Phosphate have been shown to be interchangeable (bioequivalent), allowing switch between routes when clinically appropriate. Tedizolid Phosphate should only be used for the dose and duration prescribed by a qualified healthcare professional; the safety and efficacy of Tedizolid Phosphate beyond 6 days of treatment have not been established.
Tedizolid Phosphate is contraindicated in patients with a known history of hypersensitivity to Tedizolid Phosphate or to any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.